Wayne Macfadden MD, is Board Certified Psychiatrist with additional credentials in Addiction Medicine, who has over three decades of experience. Serving as the Global Medical Affairs Sleep Therapeutic Area Lead with Jazz Pharmaceuticals, Wayne Macfadden, MD, is also interested in medication-assisted treatment to address various conditions, such as alcohol use disorder.
Alcohol use disorder (AUD) remains а critical concern, impacting more than 29.5 million Americans, according to the National Survey on Drug Use and Health. The Food and Drug Administration has approved various medications to manage AUD. These medications work best with individuals who also are involved with therapy. Disulfiram is a tablet-based treatment prescribed to AUD patients undergoing detoxification and in the initial recovery phases. Its action entails creating unpleasant reactions, like headaches, nausea, and chest pain, upon consuming even small amounts of alcohol, thus making it successful in preventing relapse. Acamprosate is another drug that helps reduce alcohol cravings and increase abstinence rates for individuals undergoing alcohol detoxification. Although acamprosate does not prevent withdrawal symptoms after consuming alcohol, it can effectively complement comprehensive therapy. Another medication, naltrexone, effectively treats AUD by blocking the desirable effects of alcohol and enabling individuals to detach from its related pleasurable experiences. Naltrexone comes in tablet and injectable forms and is most effective alongside therapeutic interventions and a holistic treatment approach.
0 Comments
|
AuthorWayne Macfadden MD: Expert in both Clinical and Research Psychiatry. Archives
March 2024
Categories |